Anesth Analg 2000;91:358-361
© 2000 International Anesthesia Research Society
NEUROSURGICAL ANESTHESIA
A Randomized, Double-Blinded Comparison of Ondansetron, Droperidol, and Placebo for Prevention of Postoperative Nausea and Vomiting After Supratentorial Craniotomy
Jennifer M. Fabling, MB, ChB, FANZCA,
Tong J. Gan, MB, FRCA,
Habib E. El-Moalem, PhD,
David S. Warner, MD, and
Cecil O. Borel, MD
Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina
Address correspondence to Cecil Borel, MD, Department of Anesthesiology, DUMC Box 3094, Duke University, Durham, NC 27710. Address e-mail to borel001{at}mc.duke.edu
Nausea or vomiting occurs frequently after craniotomy. Because of the need for frequent postoperative neurological assessment, an effective antiemetic with minimal sedative side effects is needed. Therefore, we compared ondansetron to droperidol in a randomized, double-blinded, placebo-controlled study. A total of 60 adults requiring elective supratentorial craniotomy received standardized IV anesthesia with 4 mg of ondansetron, 0.625 mg of droperidol, or placebo at skin closure. The incidence of postoperative nausea, emesis, pain and sedation scores, and rescue antiemetic use were recorded at 0, 0.5, 1, 4, 8, 12, 24, and 48 h. All groups were demographically similar. Differences existed for cumulative 8, 12, and 24 h incidences of nausea (24 h, P = 0.03) and emesis (24 h, P = 0.04). Within 4 h, when maximal effect could be expected from treatment, 20% of the ondansetron group, 25% of the droperidol group and 50% of the placebo group received rescue antiemetic (P = 0.12). No differences in pain (P = 0.82) or sedation (P = 0.74) scores were detected. Both ondansetron and droperidol prevent nausea; however, only droperidol reduces emesis after supratentorial craniotomy. The dose of droperidol used was not more sedating than ondansetron. Sustained reduction in nausea and emesis over 24 h indicates a preemptive benefit of prophylactic antiemetic in this surgical population.
Implications: Nausea and vomiting after brain surgery are particularly troubling, because effective treatment may cause sedation, making postoperative neurological assessment difficult. Our study shows that both ondansetron and droperidol are effective in reducing nausea, and that droperidol is particularly effective in reducing vomiting. Neither drug caused more sedation than placebo.
This article has been cited by other articles:

|
 |

|
 |
 
B. C. Flynn and E. C. Nemergut
Postoperative nausea and vomiting and pain after transsphenoidal surgery: a review of 877 patients.
Anesth. Analg.,
July 1, 2006;
103(1):
162 - 167.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Gan
Risk factors for postoperative nausea and vomiting.
Anesth. Analg.,
June 1, 2006;
102(6):
1884 - 1898.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L Kovac
Meta-Analysis of the Use of Rescue Antiemetics Following PONV Prophylactic Failure with 5-HT3 Antagonist/Dexamethasone Versus Single-Agent Therapies
Ann. Pharmacother.,
May 1, 2006;
40(5):
873 - 887.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D Moser, J. B Caldwell, and F J. Rhule
No More Than Necessary: Safety and Efficacy of Low-Dose Promethazine
Ann. Pharmacother.,
January 1, 2006;
40(1):
45 - 48.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Gan, T. Meyer, C. C. Apfel, F. Chung, P. J. Davis, S. Eubanks, A. Kovac, B. K. Philip, D. I. Sessler, J. Temo, et al.
Consensus Guidelines for Managing Postoperative Nausea and Vomiting
Anesth. Analg.,
July 1, 2003;
97(1):
62 - 71.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Garrett, K. Tsuruta, S. Walker, S. Jackson, and M. Sweat
Managing Nausea and Vomiting: Current Strategies
Crit. Care Nurse,
February 1, 2003;
23(1):
31 - 50.
[Full Text]
[PDF]
|
 |
|
|